32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose Intensity

Publication
Article
Miami Breast Cancer Conference® Abstracts Supplement39th Annual Miami Breast Cancer Conference® - Abstracts
Volume 36
Issue suppl 3
Pages: 16

Background/Significance

Patients with breast cancer (BC) living with comorbid HIV (BCLWH) have poorer survival than patients with BC without HIV. Delayed time of treatment initiation (TTI) after BC diagnosis and reduced adjuvant chemotherapy relative dose intensity (RDI) both increase BC mortality. We aim to understand whether patients with BC with and without comorbid HIV experience differences in receipt of timely and complete BC treatment, which could contribute to survival disparities.


Materials and Methods

We used diagnostic codes from 2 centers to identify a cohort of women with stage I to III BC diagnosed between January 1, 2000, and December 31, 2018, and concurrent HIV infection. Tumor registry data were then used to identify a control cohort of patients with BC without HIV, with 2 controls matched by institution, BC stage, and year of diagnosis for each patient with BC living with HIV. Our primary end point was TTI after BC diagnosis. For patients who received neoadjuvant or adjuvant chemotherapy, we also measured RDI. We used a Cox proportional hazards model to compare TTI and a linear regression model to compare RDI.


Results

We identified 38 patients with BCLWH and matched 76 women with BC alone. They differed by race/ethnicity, relationship status, and estrogen receptor (ER) status, but had similar stage, HER2 status, and BC grade. Median TTI was 50 days (interquartile range IQR, 35-68) for patients with BCLWH and 44.5 days (IQR, 36-59.5) for control patients (HR adjusted for ER, race, and relationship status, 0.85; 95% CI, 0.58-1.56). Median chemotherapy RDI was 0.92 (IQR, 0.86-0.96) in 22 patients with BCLWH and 0.98 (IQR, 0.92-1.00) in 43 control patients (adjusted P = .008).


Conclusions

RDI was lower in patients with BCLWH; TTI was not significantly different. RDI differences do not entirely explain survival disparities in patient with BC living with HIV but may point to further differences in treatment quality. Future work will explore whether patients with BCLWH experience increased chemotherapy toxicity or if social determinants limit chemotherapy access.

Author Affiliations:

Elizabeth Rubin,1 Philippos Costa,1 Michael H. Antoni,2 Judith Hurley, MD1 Gilberto Lopes, MD1 Danial S O’Neil1

1Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL

2Department of Psychology, University of Miami, Miami, FL


Articles in this issue

15 COVID-19 Disease Course in Immunocompetent and Immunocompromised Patients  in a Breast Cancer Registry
15 COVID-19 Disease Course in Immunocompetent and Immunocompromised Patients in a Breast Cancer Registry
37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
18 Psychosocial Wellbeing and Health Care Resource Utilization Among Patients With Breast Cancer During COVID-19
18 Psychosocial Wellbeing and Health Care Resource Utilization Among Patients With Breast Cancer During COVID-19
43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy  and Symptoms
43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy and Symptoms
3 Frequency of Germline Variants in Breast Cancer Predisposing Genes: Genetic Background of Brazilian Women With Breast Cancer
3 Frequency of Germline Variants in Breast Cancer Predisposing Genes: Genetic Background of Brazilian Women With Breast Cancer
44 Implementation of a Novel Radiopaque Filament Marker at a Single Breast Cancer Surgery Center
44 Implementation of a Novel Radiopaque Filament Marker at a Single Breast Cancer Surgery Center
39TiP The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients withDCIS Following Breast Conserving Therapy
39TiP The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients withDCIS Following Breast Conserving Therapy
38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ
38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ
28 Case Series: Imaging Appearance of Non–Breast Cancer Solid Masses in the Male Breast
28 Case Series: Imaging Appearance of Non–Breast Cancer Solid Masses in the Male Breast
20 Evaluating Number, Age, and Radiographic BIRADS of Patients Visiting Mammography Unit in Baghdad, Iraq, in 2019, 2020, and 2021: A Retrospective Study
20 Evaluating Number, Age, and Radiographic BIRADS of Patients Visiting Mammography Unit in Baghdad, Iraq, in 2019, 2020, and 2021: A Retrospective Study
5 Feasibility of WF-OCT as an Adjunct to Intraoperative Specimen X-ray for Breast Conservation Surgical Specimens
5 Feasibility of WF-OCT as an Adjunct to Intraoperative Specimen X-ray for Breast Conservation Surgical Specimens
41 A Single-Centre Report on the Upgrade Rate of Complex Sclerosing Lesions of the Breast
41 A Single-Centre Report on the Upgrade Rate of Complex Sclerosing Lesions of the Breast
45 The Informed Consent Experience for Breast Cancer Surgery and Its Association With Patient Satisfaction
45 The Informed Consent Experience for Breast Cancer Surgery and Its Association With Patient Satisfaction
29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients
29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients
36 Are Positive Margins in DCIS a True Indication of Inadequate Surgery?
36 Are Positive Margins in DCIS a True Indication of Inadequate Surgery?
Related Content